Slingshot members are tracking this event:
Phase 1 Clinical Trial for ATI-50001 Initiated, an Investigational JAK Inhibitor, for the Treatment of Alopecia Totalis and Alopecia Universalis
Slingshot Insights Explained
Dec 07, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Ati-50001, Jak Inhibitor, Alopecia Areata, Ati-50002